Results 101 to 110 of about 6,004 (159)

Response to the gonadotropin releasing hormone agonist leuprolide in immature female sheep androgenized in utero

open access: yesBiological Research, 2005
Similar to women with Polycystic Ovary Syndrome (PCOS), female sheep treated prenatally with testosterone (T-females) are hypergonadotropic, exhibit neuroendocrine defects, multifollicular ovarian morphology, hyperinsulinemia and cycle defects ...
SERGIO E RECABARREN   +5 more
doaj  

GnRH agonist and antagonist: Options for endometriosis pain treatment [PDF]

open access: yes, 2006
Basic science research into the mechanism of the development of endometriosis, its persistence and resulting pain has begun to improve our understanding of how various therapeutic options work.
Batzer, Frances R.
core   +1 more source

Androgen deprivation decreases prostate specific antigen in the absence of tumor: implications for interpretation of PSA results [PDF]

open access: yes, 2017
Background: Prostate-specific antigen (PSA) is used as an outcome measure for relapsed disease in prostate cancer. Nonetheless, there are considerable concerns about its indiscriminate use as a surrogate endpoint for cell growth or survival.
Jilma, Bernd   +5 more
core  

Incorporating ulipristal acetate in the care of symptomatic uterine fibroids: a Canadian cost-utility analysis of pharmacotherapy management

open access: yesClinicoEconomics and Outcomes Research, 2015
Bernice Tsoi,1,2 Gord Blackhouse,1,2 Simon Ferrazzi,3 Clare J Reade,4 Innie Chen,5,6 Ron Goeree1,2,7 1Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, ON, Canada; 2Programs for Assessment of Technology in Health (PATH)
Tsoi B   +5 more
doaj  

Comparison of the Effects of Gonadotropin Releasing Hormone Agonists and Antagonists on Endometrial Development in Women who Had Inadequate Endometrial Development in a Previous Assisted Reproduction Treatment Cycle; A Randomised Parallel Group Pilot Trial

open access: yesGynecology Obstetrics & Reproductive Medicine, 2008
OBJECTIVE: To analyse the effects of GnRH agonist or antagonist administration on endometrium of patients with poor prognostic feasures of endometrium undergoing IVF STUDY DESIGN: A randomised controlled trial was done in 152 women undergoing an assisted
Özkan Aydın Leylek   +4 more
doaj  

Six-month gonadotropin releasing hormone (GnRH) agonist depots provide efficacy, safety, convenience, and comfort

open access: yesCancer Management and Research, 2011
E David Crawford, Jason M PhillipsUniversity of Colorado Health Sciences Center, Aurora, CO, USAAbstract: Two different 6-month GnRH agonist depot formulations approved for palliative treatment of advanced and metastatic prostate cancer in the United ...
Phillips JM, Crawford ED
doaj  

Home - About - Disclaimer - Privacy